Manela Scaramuzzino
Manela Scaramuzzino has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Bruna Sinjari
Unit of Prosthodontics, Department of Innovative Technologies in Medicine and Dentistry, University “G. d’Annunzio” of Chieti-Pescara, 66100 Chieti, Italy
6 shared publications - Elisabetta Ferrara
Department of Human Sciences, Law, and Economics, Telematic University “Leonardo da Vinci”, UNIDAV, Torrevecchia Teatina, 66100 Chieti, Italy
6 shared publications - Giovanna Murmura
Department of Innovative Technologies in Medicine and Dentistry, University of Chieti-Pescara, Chieti, Italy, Italy
5 shared publications - Gianmaria D’ Addazio
Unit of Prosthodontics, Department of Innovative Technologies in Medicine and Dentistry, University “G. d’Annunzio” of Chieti-Pescara, 66100 Chieti, Italy
2 shared publications - Giuseppe Balice
Unit of Prosthodontics, Department of Innovative Technologies in Medicine and Dentistry, University “G. d’Annunzio” of Chieti-Pescara, 66100 Chieti, Italy
2 shared publications - Andrea Carugno
Dermatology Unit, Ospedale di Circolo e Fondazione Macchi, ASST Sette Laghi, 21100 Varese, Italy
1 shared publication
Latest Publications
- Open Access
Balneotherapy as Adjunctive Care in Atopic Dermatitis: Effects on Skin Barrier, Microbiome, and Pruritus
Atopic dermatitis (AD) is a chronic inflammatory skin disease in which type 2 immune activation, epidermal barrier dysfunction, microbial dysbiosis, and neurosensory pathways interact to sustain disease activity and symptom burden. Despite major advances with biologics and Janus kinase inhibitors, residual xerosis, pruritus, sleep disturbance, and barrier fragility may persist in otherwise controlled patients. This narrative review evaluates balneotherapy as adjunctive supportive care in AD, focusing on skin barrier function, microbiome-related effects, pruritus, and clinical integration. A narrative literature review was conducted using PubMed/MEDLINE, Ovid, and Scopus from database inception to 31 December 2025. Search terms addressed AD, type 2 inflammation, skin barrier dysfunction, transepidermal water loss, pruritus, microbiome dysbiosis, thermal spring water, spa therapy, seawater therapy, Dead Sea climatotherapy, hydrotherapy, and balneophototherapy. Clinical, mechanistic, translational, and methodological studies were considered. Available evidence suggests that water-based interventions may improve selected patient-centred outcomes, particularly xerosis-related discomfort, pruritus, sleep impairment, quality of life, and global severity scores. Thermal spring water programmes, Dead Sea climatotherapy, seawater-based approaches, and balneophototherapy differ substantially in exposure characteristics, co-interventions, and outcome reporting. Objective endpoints such as transepidermal water loss, skin hydration, tape stripping biomarkers, and microbiome profiling may help clarify biological plausibility, although current evidence is limited by heterogeneity, short follow-up, and difficulty isolating water-specific effects. Balneotherapy should be positioned as an adjunctive, supportive intervention rather than an alternative to evidence-based anti-inflammatory therapy in AD, particularly for selected patients with persistent barrier- and symptom-dominant residual burden.
Open AccessBalneotherapy as Adjunctive Care in Atopic Dermatitis: Effects on Skin Barrier, Microbiome, and Pruritus
Atopic dermatitis (AD) is a chronic inflammatory skin disease in which type 2 immune activation, epidermal barrier dysfunction, microbial dysbiosis, and neurosensory pathways interact to sustain disease activity and symptom burden. Despite major advances with biologics and Janus kinase inhibitors, residual xerosis, pruritus, sleep disturbance, and barrier fragility may persist in otherwise controlled patients. This narrative review evaluates balneotherapy as adjunctive supportive care in AD, focusing on skin barrier function, microbiome-related effects, pruritus, and clinical integration. A narrative literature review was conducted using PubMed/MEDLINE, Ovid, and Scopus from database inception to 31 December 2025. Search terms addressed AD, type 2 inflammation, skin barrier dysfunction, transepidermal water loss, pruritus, microbiome dysbiosis, thermal spring water, spa therapy, seawater therapy, Dead Sea climatotherapy, hydrotherapy, and balneophototherapy. Clinical, mechanistic, translational, and methodological studies were considered. Available evidence suggests that water-based interventions may improve selected patient-centred outcomes, particularly xerosis-related discomfort, pruritus, sleep impairment, quality of life, and global severity scores. Thermal spring water programmes, Dead Sea climatotherapy, seawater-based approaches, and balneophototherapy differ substantially in exposure characteristics, co-interventions, and outcome reporting. Objective endpoints such as transepidermal water loss, skin hydration, tape stripping biomarkers, and microbiome profiling may help clarify biological plausibility, although current evidence is limited by heterogeneity, short follow-up, and difficulty isolating water-specific effects. Balneotherapy should be positioned as an adjunctive, supportive intervention rather than an alternative to evidence-based anti-inflammatory therapy in AD, particularly for selected patients with persistent barrier- and symptom-dominant residual burden.
- Open Access
- 19 March 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (6) , 782
Short-Term Sulfurous Balneotherapy and Self-Reported Sleep Quality: An Exploratory Retrospective Real-World Pre–Post Observational Study at Terme di Saturnia (Italy)
Background: Sleep disturbances are highly prevalent, affecting approximately 21% of the European population, with chronic insomnia disorder estimated at 6%. Non-pharmacological alternatives to pharmacotherapy are needed. Sulfurous balneotherapy represents a potential intervention, yet real-world evidence remains limited. Objective: To explore changes in self-reported sleep quality following sulfurous balneotherapy at Terme di Saturnia (Italy). Methods: Retrospective single-arm observational study of 76 participants (mean age 47.3 years, 54% female) undergoing a 7–12-day consecutive balneotherapy cycle with daily sulfurous thermal water immersion sessions (60–90 min/session). The Oviedo Sleep Questionnaire (OSQ) was administered pre- and post-treatment. Participants were stratified by baseline insomnia severity into Group A (OSQ ≥ 22, n = 47) and Group B (OSQ < 22, n = 29). The primary outcome was change in OSQ insomnia score in Group A. Statistical analysis was performed using the Wilcoxon signed-rank test. Results: In Group A, insomnia severity decreased significantly from 26.4 ± 8.3 at baseline to 20.1 ± 7.5 post-treatment (Δ = −6.3, 95% CI: −7.9 to −4.7, p < 0.001, r = 0.54). Sleep satisfaction also improved significantly from 3.2 ± 1.1 to 4.6 ± 1.2 (Δ = +1.4, 95% CI: 1.1–1.7, p < 0.001, r = 0.60). In Group B, no statistically significant changes were observed, consistent with ceiling effects. However, in an open-ended question, 72.4% (21/29; 95% CI: 54.3–85.3) of Group B participants reported enhanced relaxation during the spa stay. Due to the single-arm observational design without control groups, the observed improvements cannot be distinguished from non-specific factors, including the vacation effect, reduced work-related stress, placebo and expectancy responses, regression to the mean, or the effects of warm water immersion itself independent of sulfurous mineral content. Conclusions: This exploratory study documents pre–post improvements in self-reported sleep quality in a cohort undergoing sulfurous balneotherapy during a spa vacation. The absence of control groups and unmeasured confounders precludes causal inferences. Future randomized trials with heated non-mineral water controls are needed to isolate specific therapeutic contributions of sulfurous thermal waters.
- 19 March 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (6) , 782
Open AccessShort-Term Sulfurous Balneotherapy and Self-Reported Sleep Quality: An Exploratory Retrospective Real-World Pre–Post Observational Study at Terme di Saturnia (Italy)
Background: Sleep disturbances are highly prevalent, affecting approximately 21% of the European population, with chronic insomnia disorder estimated at 6%. Non-pharmacological alternatives to pharmacotherapy are needed. Sulfurous balneotherapy represents a potential intervention, yet real-world evidence remains limited. Objective: To explore changes in self-reported sleep quality following sulfurous balneotherapy at Terme di Saturnia (Italy). Methods: Retrospective single-arm observational study of 76 participants (mean age 47.3 years, 54% female) undergoing a 7–12-day consecutive balneotherapy cycle with daily sulfurous thermal water immersion sessions (60–90 min/session). The Oviedo Sleep Questionnaire (OSQ) was administered pre- and post-treatment. Participants were stratified by baseline insomnia severity into Group A (OSQ ≥ 22, n = 47) and Group B (OSQ < 22, n = 29). The primary outcome was change in OSQ insomnia score in Group A. Statistical analysis was performed using the Wilcoxon signed-rank test. Results: In Group A, insomnia severity decreased significantly from 26.4 ± 8.3 at baseline to 20.1 ± 7.5 post-treatment (Δ = −6.3, 95% CI: −7.9 to −4.7, p < 0.001, r = 0.54). Sleep satisfaction also improved significantly from 3.2 ± 1.1 to 4.6 ± 1.2 (Δ = +1.4, 95% CI: 1.1–1.7, p < 0.001, r = 0.60). In Group B, no statistically significant changes were observed, consistent with ceiling effects. However, in an open-ended question, 72.4% (21/29; 95% CI: 54.3–85.3) of Group B participants reported enhanced relaxation during the spa stay. Due to the single-arm observational design without control groups, the observed improvements cannot be distinguished from non-specific factors, including the vacation effect, reduced work-related stress, placebo and expectancy responses, regression to the mean, or the effects of warm water immersion itself independent of sulfurous mineral content. Conclusions: This exploratory study documents pre–post improvements in self-reported sleep quality in a cohort undergoing sulfurous balneotherapy during a spa vacation. The absence of control groups and unmeasured confounders precludes causal inferences. Future randomized trials with heated non-mineral water controls are needed to isolate specific therapeutic contributions of sulfurous thermal waters.
- Open Access
- 27 January 2026
- Published by MDPI AG in Preprints.org
Short-Term Sulfurous Balneotherapy and Self-Reported Sleep Quality: An Exploratory Retrospective Real-World Pre–Post Observational Study at Terme di Saturnia (Italy)
Background: Background: Sleep disturbances are highly prevalent, affecting approximately 21% of the European population, with chronic insomnia disorder estimated at 6%. Non-pharmacological alternatives to pharmacotherapy are needed. Sulfurous balneotherapy represents a potential intervention, yet real-world evidence remains limited. Objective: To explore changes in self-reported sleep quality following sulfurous balneotherapy at Terme di Saturnia (Italy). Methods: Retrospective single-arm observational study of 76 participants (mean age 47.3 years, 54% female) undergoing a 7–12-day consecutive balneotherapy cycle with daily sulfurous thermal water immersion sessions (60–90 min/session). The Oviedo Sleep Questionnaire (OSQ) was administered pre- and post-treatment. Participants were stratified by baseline insomnia severity into Group A (OSQ ≥22, n = 47) and Group B (OSQ Results: In Group A, insomnia severity decreased significantly from 26.4±8.3 at baseline to 20.1±7.5 post-treatment (Δ = −6.3, 95% CI: −7.9 to −4.7, p < 0.001, r = 0.54). Sleep satisfaction also improved significantly from 3.2±1.1 to 4.6±1.2 (Δ = +1.4, 95% CI: 1.1–1.7, p < 0.001, r = 0.60). In Group B, no statistically significant changes were observed, consistent with ceiling effects. However, in an open-ended question, 72.4% (21/29; 95% CI: 54.3–85.3) of Group B participants reported enhanced relaxation during the spa stay. These findings are hypothesis-generating and support further evaluation of balneotherapy as a complementary, patient-centered approach within sleep health pathways. Nevertheless, without control groups, the observed improvements cannot be attributed specifically to sulfurous water properties versus vacation effects, placebo responses, or regression to the mean. Conclusions: This exploratory study documents substantial pre-post improvements in sleep quality following balneotherapy. The absence of control groups and unmeasured confounders preclude causal inferences. Future randomized trials with heated non-mineral water controls are needed to isolate specific therapeutic contributions of sulfurous thermal waters.
- 27 January 2026
- Published by MDPI AG in Preprints.org
Open AccessShort-Term Sulfurous Balneotherapy and Self-Reported Sleep Quality: An Exploratory Retrospective Real-World Pre–Post Observational Study at Terme di Saturnia (Italy)
Background: Background: Sleep disturbances are highly prevalent, affecting approximately 21% of the European population, with chronic insomnia disorder estimated at 6%. Non-pharmacological alternatives to pharmacotherapy are needed. Sulfurous balneotherapy represents a potential intervention, yet real-world evidence remains limited. Objective: To explore changes in self-reported sleep quality following sulfurous balneotherapy at Terme di Saturnia (Italy). Methods: Retrospective single-arm observational study of 76 participants (mean age 47.3 years, 54% female) undergoing a 7–12-day consecutive balneotherapy cycle with daily sulfurous thermal water immersion sessions (60–90 min/session). The Oviedo Sleep Questionnaire (OSQ) was administered pre- and post-treatment. Participants were stratified by baseline insomnia severity into Group A (OSQ ≥22, n = 47) and Group B (OSQ Results: In Group A, insomnia severity decreased significantly from 26.4±8.3 at baseline to 20.1±7.5 post-treatment (Δ = −6.3, 95% CI: −7.9 to −4.7, p < 0.001, r = 0.54). Sleep satisfaction also improved significantly from 3.2±1.1 to 4.6±1.2 (Δ = +1.4, 95% CI: 1.1–1.7, p < 0.001, r = 0.60). In Group B, no statistically significant changes were observed, consistent with ceiling effects. However, in an open-ended question, 72.4% (21/29; 95% CI: 54.3–85.3) of Group B participants reported enhanced relaxation during the spa stay. These findings are hypothesis-generating and support further evaluation of balneotherapy as a complementary, patient-centered approach within sleep health pathways. Nevertheless, without control groups, the observed improvements cannot be attributed specifically to sulfurous water properties versus vacation effects, placebo responses, or regression to the mean. Conclusions: This exploratory study documents substantial pre-post improvements in sleep quality following balneotherapy. The absence of control groups and unmeasured confounders preclude causal inferences. Future randomized trials with heated non-mineral water controls are needed to isolate specific therapeutic contributions of sulfurous thermal waters.
- Open Access
- 1 December 2025
- Published by MDPI AG in Preprints.org
From Thermal Springs to Saline Solutions: A Scoping Review of Salt-Based Oral Healthcare Interventions
Background: Therapeutic applications of saline solutions in oral healthcare range from mineral waters to standardized sodium chloride preparations. Despite widespread traditional use, their scientific foundation remains inadequately characterized. This scoping review aimed to map the available evidence for saline interventions in oral healthcare and identify research gaps. Methods: Following JBI methodology and PRISMA-ScR guidelines, four electronic databases (PubMed, Scopus, Web of Science, Cochrane Library) were systematically searched for publications from 2000 to 2025. Studies were classified along a spectrum from geological mineral waters to artificial preparations. Narrative synthesis was employed with systematic gap identification. Results: Seventeen studies met inclusion criteria, with a median sample size of 41 participants and median follow-up of 4 weeks. Evidence distribution revealed concentration on hypersaline Dead Sea derivatives (n=7, 41%) and European thermal waters (n=6, 35%), with limited representation of marine-derived (n=1, 6%) and simple saline solutions (n=3, 18%). Reported outcomes included periodontal parameters, xerostomia symptoms, viral load, mucositis severity, and dentin hypersensitivity, with variable methodological quality across studies. Heterogeneity in interventions, comparators, and outcome measures precluded direct comparisons. Conclusions: The current evidence base for salt-based oral interventions remains limited and methodologically heterogeneous. While preliminary findings suggest potential applications across multiple clinical domains, small sample sizes, short follow-up periods, and inconsistent outcome measures preclude definitive recommendations. Standardized protocols and adequately powered trials are needed before evidence-based clinical integration.
- 1 December 2025
- Published by MDPI AG in Preprints.org
Open AccessFrom Thermal Springs to Saline Solutions: A Scoping Review of Salt-Based Oral Healthcare Interventions
Background: Therapeutic applications of saline solutions in oral healthcare range from mineral waters to standardized sodium chloride preparations. Despite widespread traditional use, their scientific foundation remains inadequately characterized. This scoping review aimed to map the available evidence for saline interventions in oral healthcare and identify research gaps. Methods: Following JBI methodology and PRISMA-ScR guidelines, four electronic databases (PubMed, Scopus, Web of Science, Cochrane Library) were systematically searched for publications from 2000 to 2025. Studies were classified along a spectrum from geological mineral waters to artificial preparations. Narrative synthesis was employed with systematic gap identification. Results: Seventeen studies met inclusion criteria, with a median sample size of 41 participants and median follow-up of 4 weeks. Evidence distribution revealed concentration on hypersaline Dead Sea derivatives (n=7, 41%) and European thermal waters (n=6, 35%), with limited representation of marine-derived (n=1, 6%) and simple saline solutions (n=3, 18%). Reported outcomes included periodontal parameters, xerostomia symptoms, viral load, mucositis severity, and dentin hypersensitivity, with variable methodological quality across studies. Heterogeneity in interventions, comparators, and outcome measures precluded direct comparisons. Conclusions: The current evidence base for salt-based oral interventions remains limited and methodologically heterogeneous. While preliminary findings suggest potential applications across multiple clinical domains, small sample sizes, short follow-up periods, and inconsistent outcome measures preclude definitive recommendations. Standardized protocols and adequately powered trials are needed before evidence-based clinical integration.
- Open Access
- 3 July 2025
- Published by MDPI AG in Preprints.org
Geochemical Perspectives Intercept Therapeutic Properties of Saturnia Thermal Waters: A Retrospective Cohort Study
Background: Saturnia thermal waters, characterized by unique calcium-sulfate composition and high hydrogen sulfide (H₂S) concentrations, have been traditionally used for therapeutic purposes. Despite emerging molecular evidence of H₂S's immunomodulatory properties, the relationship between specific geochemical parameters and measurable health outcomes remains poorly quantified. This study aimed to determine the association between H₂S concentration and quality of life outcomes under different exposure protocols. Methods: We conducted a retrospective analysis of medical records from adult patients (≥18 years) who underwent balneotherapy at Saturnia Thermal Center between January 2016 and December 2023. Participants (N=190) were stratified into acute (2-3 hours, n=114) and sustained exposure (3-14 days, n=76) cohorts. Primary outcomes included changes in SF-36 Physical Component Summary (PCS) and WHOQOL-BREF physical health domain scores. Secondary outcomes comprised pain reduction (Visual Analog Scale) and dermatological life quality (DLQI). Geochemical profiles, including H₂S concentration, pH, mineral content, and temperature, were measured daily. Multiple regression analyses and Pearson correlations assessed relationships between geochemical parameters and health outcomes, adjusting for age, gender, and treatment duration. Results: The sustained exposure cohort demonstrated greater improvements in SF-36 PCS (mean change = 11.7 [95% CI: 9.8, 13.6], d = 0.67 [95% CI: 0.54, 0.80]) compared to acute exposure (mean change = 7.3 [95% CI: 5.9, 8.7], d = 0.41 [95% CI: 0.32, 0.50]). H₂S concentration emerged as the strongest predictor of outcome improvement (β = 0.28 [95% CI: 0.15, 0.41], R² = 0.458), with significant correlations observed for both pain reduction (r = -0.42 [95% CI: -0.51, -0.32]) and quality of life enhancement (r = 0.45 [95% CI: 0.35, 0.55]). No serious adverse events were reported during the study period. Conclusions: Higher H₂S concentrations in Saturnia thermal waters significantly correlate with improved physical health outcomes, particularly during sustained exposure protocols. Future randomized controlled trials should investigate optimal exposure durations and H₂S concentration thresholds for specific therapeutic applications.
- 3 July 2025
- Published by MDPI AG in Preprints.org
Open AccessGeochemical Perspectives Intercept Therapeutic Properties of Saturnia Thermal Waters: A Retrospective Cohort Study
Background: Saturnia thermal waters, characterized by unique calcium-sulfate composition and high hydrogen sulfide (H₂S) concentrations, have been traditionally used for therapeutic purposes. Despite emerging molecular evidence of H₂S's immunomodulatory properties, the relationship between specific geochemical parameters and measurable health outcomes remains poorly quantified. This study aimed to determine the association between H₂S concentration and quality of life outcomes under different exposure protocols. Methods: We conducted a retrospective analysis of medical records from adult patients (≥18 years) who underwent balneotherapy at Saturnia Thermal Center between January 2016 and December 2023. Participants (N=190) were stratified into acute (2-3 hours, n=114) and sustained exposure (3-14 days, n=76) cohorts. Primary outcomes included changes in SF-36 Physical Component Summary (PCS) and WHOQOL-BREF physical health domain scores. Secondary outcomes comprised pain reduction (Visual Analog Scale) and dermatological life quality (DLQI). Geochemical profiles, including H₂S concentration, pH, mineral content, and temperature, were measured daily. Multiple regression analyses and Pearson correlations assessed relationships between geochemical parameters and health outcomes, adjusting for age, gender, and treatment duration. Results: The sustained exposure cohort demonstrated greater improvements in SF-36 PCS (mean change = 11.7 [95% CI: 9.8, 13.6], d = 0.67 [95% CI: 0.54, 0.80]) compared to acute exposure (mean change = 7.3 [95% CI: 5.9, 8.7], d = 0.41 [95% CI: 0.32, 0.50]). H₂S concentration emerged as the strongest predictor of outcome improvement (β = 0.28 [95% CI: 0.15, 0.41], R² = 0.458), with significant correlations observed for both pain reduction (r = -0.42 [95% CI: -0.51, -0.32]) and quality of life enhancement (r = 0.45 [95% CI: 0.35, 0.55]). No serious adverse events were reported during the study period. Conclusions: Higher H₂S concentrations in Saturnia thermal waters significantly correlate with improved physical health outcomes, particularly during sustained exposure protocols. Future randomized controlled trials should investigate optimal exposure durations and H₂S concentration thresholds for specific therapeutic applications.
- Open Access
- 20 January 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (2) , 202
COVID-19-Related Discontinuation Impact on Patient-Reported Outcomes in Long-Term Thermal Therapy: A Single-Center Observational Study at Saturnia Thermal Springs
Background: Thermal therapy represents a well-established therapeutic approach for chronic musculoskeletal and respiratory conditions. To date, no studies have investigated the clinical effects of treatment interruption in thermal medicine. We aimed to evaluate the clinical impact of COVID-19 lockdown-induced thermal therapy discontinuation through validated patient-reported outcomes. Methods: This single-center observational, retrospective study (March 2020–June 2024) evaluated 97 patients receiving standardized thermal therapy at Saturnia Thermal Springs. Treatment protocols included balneotherapy, mud therapy, and inhalation treatments in cycles of 12–15 sessions, with maintenance protocols every 4–6 months. Primary outcomes were assessed through VAS and SF-36 PCS, with EQ-5D and PSQI as secondary outcomes. Results: Significant clinical deterioration occurred during treatment interruption (p < 0.001) in 77.7% of patients. Recovery patterns were duration-dependent, with the 6–7-year cohort showing faster recovery (mean time to baseline: 2.8 months) compared to the 3–5-year cohort (4.6 months). Effect sizes were substantial across all outcomes (Cohen’s d > 1.0), with EQ-5D scores showing duration-dependent improvement (mean improvement in 6–7-year cohort: 0.27). Conclusions: Thermal therapy interruption precipitates quantifiable clinical deterioration, with recovery patterns significantly influenced by pre-existing treatment duration. These findings support the essential nature of treatment continuity in thermal therapy protocols.
- 20 January 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (2) , 202
Open AccessCOVID-19-Related Discontinuation Impact on Patient-Reported Outcomes in Long-Term Thermal Therapy: A Single-Center Observational Study at Saturnia Thermal Springs
Background: Thermal therapy represents a well-established therapeutic approach for chronic musculoskeletal and respiratory conditions. To date, no studies have investigated the clinical effects of treatment interruption in thermal medicine. We aimed to evaluate the clinical impact of COVID-19 lockdown-induced thermal therapy discontinuation through validated patient-reported outcomes. Methods: This single-center observational, retrospective study (March 2020–June 2024) evaluated 97 patients receiving standardized thermal therapy at Saturnia Thermal Springs. Treatment protocols included balneotherapy, mud therapy, and inhalation treatments in cycles of 12–15 sessions, with maintenance protocols every 4–6 months. Primary outcomes were assessed through VAS and SF-36 PCS, with EQ-5D and PSQI as secondary outcomes. Results: Significant clinical deterioration occurred during treatment interruption (p < 0.001) in 77.7% of patients. Recovery patterns were duration-dependent, with the 6–7-year cohort showing faster recovery (mean time to baseline: 2.8 months) compared to the 3–5-year cohort (4.6 months). Effect sizes were substantial across all outcomes (Cohen’s d > 1.0), with EQ-5D scores showing duration-dependent improvement (mean improvement in 6–7-year cohort: 0.27). Conclusions: Thermal therapy interruption precipitates quantifiable clinical deterioration, with recovery patterns significantly influenced by pre-existing treatment duration. These findings support the essential nature of treatment continuity in thermal therapy protocols.
- Top Cited PapersOpen Access
- 7 January 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (2) , 96
Emerging Evidence on Balneotherapy and Thermal Interventions in Post-COVID-19 Syndrome: A Systematic Review
Background: Post-COVID-19 syndrome affects 10–60% of SARS-CoV-2 survivors. While conventional treatments show limited efficacy, emerging evidence suggests the potential benefits of balneotherapy in managing persistent symptoms. We aimed to systematically evaluate the efficacy and safety of balneotherapy and thermal treatment interventions in treating post-COVID-19 syndrome. Methods: We conducted a systematic review following PRISMA guidelines, searching major databases through 31 January 2024. Eligible studies included randomized controlled trials, observational studies, and pilot studies investigating thermal spa treatments for adult post-COVID-19 patients. Results: Analysis of six eligible studies (n = 617) demonstrated significant therapeutic benefits. The largest cohort (n = 159) showed 47% reduction in fatigue and 48% reduction in muscle pain (p < 0.01). Comprehensive spa therapy achieved complete symptom resolution in one-third of the participants. Combined spa-ubiquinol therapy improved metabolic function (p < 0.05). All interventions demonstrated favorable safety profiles. Conclusions: Preliminary evidence suggests balneotherapy effectively ameliorates multiple post-COVID-19 symptoms, particularly fatigue, muscle pain, and exercise intolerance. While safety profiles appear favorable, larger randomized controlled trials with standardized protocols are needed to establish definitive therapeutic recommendations.
- 7 January 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (2) , 96
Top Cited PapersOpen AccessEmerging Evidence on Balneotherapy and Thermal Interventions in Post-COVID-19 Syndrome: A Systematic Review
Background: Post-COVID-19 syndrome affects 10–60% of SARS-CoV-2 survivors. While conventional treatments show limited efficacy, emerging evidence suggests the potential benefits of balneotherapy in managing persistent symptoms. We aimed to systematically evaluate the efficacy and safety of balneotherapy and thermal treatment interventions in treating post-COVID-19 syndrome. Methods: We conducted a systematic review following PRISMA guidelines, searching major databases through 31 January 2024. Eligible studies included randomized controlled trials, observational studies, and pilot studies investigating thermal spa treatments for adult post-COVID-19 patients. Results: Analysis of six eligible studies (n = 617) demonstrated significant therapeutic benefits. The largest cohort (n = 159) showed 47% reduction in fatigue and 48% reduction in muscle pain (p < 0.01). Comprehensive spa therapy achieved complete symptom resolution in one-third of the participants. Combined spa-ubiquinol therapy improved metabolic function (p < 0.05). All interventions demonstrated favorable safety profiles. Conclusions: Preliminary evidence suggests balneotherapy effectively ameliorates multiple post-COVID-19 symptoms, particularly fatigue, muscle pain, and exercise intolerance. While safety profiles appear favorable, larger randomized controlled trials with standardized protocols are needed to establish definitive therapeutic recommendations.